In her role as co-founder and chief medical and science officer of Geneoscopy, Dr. Erica Barnell has both innovated diagnostic technology and scaled the startup that delivers it. Since founding the company in 2015, she has raised more than $220 million across multiple venture rounds. The company’s lead diagnostic, ColoSense, is an FDA-approved, noninvasive multi-target RNA screening test for colorectal cancer…
